Skip to content

Effects of electrical stimulation therapy in patients with advanced cancer: A feasibility and safety study

Effects of Neuromuscular Electrical Stimulation Therapy on Patients with Advanced Cancer: A Preliminary Study on Implementation Rate and Safety - Effects of Neuromuscular Electrical Stimulation Therapy on Patients with Advanced Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000054942
Enrollment
58
Registered
2024-07-14
Start date
2024-04-17
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients aged 18 years or older with advanced or recurrent cancer.

Interventions

Intervention Group: In addition to following a standard exercise therapy programme similar to the control group, the NMES group will also receive NMES. The NMES treatment will be administered using th

Sponsors

Social Medical Corporation Yurin-kai, Higashiosaka Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients aged 18 years or older with advanced or recurrent cancer (with evidence of locally advanced disease or histological, cytological, or radiological metastases). 2. Patients who have been provided with comprehensive information regarding their participation in the study and who have provided written consent to take part in the study of their own volition, having had sufficient time to consider the implications of their participation.

Exclusion criteria

Exclusion criteria: 1. Presence of cancer metastases in the thigh area to be treated with NMES 2. Cognitive impairment that prevents understanding or compliance with physical function assessment or exercise instructions 3. Determination by treating physician that participation is inappropriate 4. Planned early discharge 5. Patient or family request to withdraw from the study

Design outcomes

Primary

MeasureTime frame
1. NMES implementation rate 2. Adverse events (Myalgia,Purpura,Fatigue,Pain of skin) assessed using CTCAE v5.0

Secondary

MeasureTime frame
1. Knee extension strength 2. Quadriceps muscle thickness 3. Timed Up and Go (TUG) test 4. Five times chair stand test

Countries

Japan

Contacts

Public ContactKazutoshi Nakanishi

Social Medical Corporation Yurin-kai, Higashiosaka Hospital Rehabilitation Department

riha@yurin.or.jp0669338133

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026